Analyst Jonathan Wolleben of JMP Securities reiterated a Buy rating on Madrigal Pharmaceuticals (MDGL – Research Report), with a price target ...
Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon Recent sales of a little-known stock, Madrigal Pharmaceuticals (NASDAQ:MDGL), could bode well for Novo Nordisk A/S (NYSE:NVO). The pharma ...
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the Company will present at the 43 rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025 at 2:15 pm PT. The ...